Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:smartphone
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Vanderbilt-Ingram_Cancer_Center
gptkb:MD_Anderson_Cancer_Center |
| gptkbp:associated_with |
Tumorigenesis
|
| gptkbp:can_create |
Various Cell Types
Specific Markers |
| gptkbp:contribution |
Metastasis
|
| gptkbp:developed_by |
Normal Stem Cells
|
| gptkbp:established |
Specific Drugs
|
| gptkbp:exhibits |
gptkb:Differentiation
Self-renewal |
| gptkbp:has_role |
Recurrence
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cancer Stem Cells
|
| gptkbp:is_aimed_at |
gptkb:CRISPR_Technology
gptkb:Gene_Therapy gptkb:vaccine Monoclonal Antibodies Targeted Therapy Combination Therapy Small Molecule Inhibitors Nanoparticle Delivery Systems |
| gptkbp:is_analyzed_in |
Single-cell Sequencing
|
| gptkbp:is_associated_with |
Therapeutic Resistance
Invasive Phenotype |
| gptkbp:is_characterized_by |
Altered Gene Expression
High Tumorigenic Potential Metabolic Changes |
| gptkbp:is_found_in |
gptkb:Hematological_Malignancies
Solid Tumors |
| gptkbp:is_influenced_by |
Microenvironment
|
| gptkbp:is_involved_in |
gptkb:Tumor_Microenvironment
Angiogenesis Tumor Immunology Cell Cycle Regulation Cell Migration Cell Signaling Pathways Tumor Growth Tumor Progression Cell-Cell Interactions Immune Evasion Tumor Heterogeneity Cellular Plasticity Cell Survival Mechanisms Drug Resistance Mechanisms |
| gptkbp:is_linked_to |
Poor Prognosis
|
| gptkbp:is_recognized_by |
Flow Cytometry
Cell Surface Markers |
| gptkbp:is_studied_in |
gptkb:Cancer_Research
gptkb:legal_case Animal Models Therapeutic Strategies Therapeutic Efficacy Biomarker Discovery Novel Treatment Approaches Prognostic Indicators |
| gptkbp:is_subject_to |
Epigenetic Regulation
|
| gptkbp:language |
Laboratory Conditions
|
| gptkbp:replaced_by |
Bone Marrow
Peripheral Blood Tumor Biopsies |
| gptkbp:was_marked_by |
gptkb:Ep_CAM
ALDH C D133 C D24 C D44 |
| gptkbp:water_resistance |
Chemotherapy
Radiation Therapy |